Wellcome Trust Sanger Institute

Medications

New drug combinations found for resistant cancers

Sanger researchers have created the world's largest novel resource using systematic drug testing and genetics analyses to show new potential drug combinations for breast, colon, and pancreatic cancer.

Genetics

Genetic history of British Pakistanis mapped for the first time

The first fine-scale analysis of genetic diversity within the British Pakistani population has been conducted by researchers at the Wellcome Sanger Institute, the University of Leeds, the Bradford Institute for Health Research ...

Diseases, Conditions, Syndromes

Mutations in liver cells linked to liver disease and fat metabolism

For the first time, DNA mutations in liver cells have been identified that impact metabolism and insulin sensitivity in patients with liver disease. These mutations are specific to liver disease that is associated with obesity, ...

Medical research

Development study reveals origins of inflammatory bowel disease

Many diseases have their origin in early human development, and today (8 September), two publications in Nature reveal how researchers from the Human Cell Atlas (HCA) consortium are advancing understanding of this. The global ...

page 6 from 36